通过诱导铁亡,FLRT2抑制了膀癌的进展
Pengcheng Jiang1, Jinzhuo Ning1, Weimin Yu1
1Department of Urology, Renmin Hospital of Wuhan University, Wuhan, China.
Journal of cellular and molecular medicine
|July 22, 2023
概括
在膀癌中,富含纤维素氨酸的跨膜蛋白2 (FLRT2) 作为瘤抑制剂起作用. 较低的FLRT2水平与预后不佳相关,而其升高则通过铁亡抑制了癌症的进展.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 膀癌是一种常见的恶性瘤,预后不佳.
- 在膀癌的发病过程中,富含纤维素氨酸的跨膜蛋白2 (FLRT2) 的作用尚不清楚.
研究的目的:
- 为了研究FLRT2在人类膀癌中的功能.
- 阐明FLRT2在膀癌中的作用背后的分子机制.
主要方法:
- 在人类膀癌组织中分析FLRT2表达水平.
- 在体外研究涉及FLRT2过度表达和沉默在膀癌细胞系.
- 研究下游目标和细胞过程,包括脂质过氧化和铁.
主要成果:
- 在人类膀癌组织中,FLRT2的表达减少.
- 较高的FLRT2水平与较低的生存率有关.
- 过度表达FLRT2抑制了瘤细胞的生长,迁移和入侵.
- FLRT2沉默促进了瘤细胞的增殖,迁移和入侵.
- 在FLRT2上调节了长链乙基-CoA合成酶家族成员4 (ACSL4) 的表达.
- FLRT2促进脂质过氧化,并诱导膀癌细胞中的铁亡.
结论:
- 在膀癌中,FLRT2作为瘤抑制基因起作用.
- 通过提高ACSL4的表达,增加脂质过氧化,并触发铁亡,FLRT2抑制了膀癌的进展.
相关概念视频
The Retinoblastoma Gene
4.1K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.1K
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K


